Parexel co-designed NDA templates with Weave Bio and reports 60% faster authoring.
NDA authoring is slow manual document work for CROs. Parexel served as design partner for Weave Bio's AI platform and is deploying it for client submissions, with qualified regulators in control. The page reports 60% faster NDA authoring timelines and says Parexel has exclusivity over the co-developed templates.
Weave Bio is an AI-native regulatory automation platform, used by pharma, biotech and CROs to draft IND and NDA content and respond to health authority questions
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Weave Bio on its own site — read the original case study on bioxconomy.com ↗
Note: Trade-press coverage of the vendor's claim.
Related use cases
- 01Trace Biosciences prepared its first IND submission using Weave Bio's Submission Builder.
- 02Takeda expanded Weave Bio's AI regulatory platform across 14 drug development programs.
- 03Transforming Content Operations for 2x Faster Time to Market
- 04Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 05How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 06Reaching Underserved Communities with Smarter Targeting